258 related articles for article (PubMed ID: 10082129)
21. Protein kinase C delta blocks immediate-early gene expression in senescent cells by inactivating serum response factor.
Wheaton K; Riabowol K
Mol Cell Biol; 2004 Aug; 24(16):7298-311. PubMed ID: 15282327
[TBL] [Abstract][Full Text] [Related]
22. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
Skerka C; Decker EL; Zipfel PF
Immunobiology; 1997 Dec; 198(1-3):179-91. PubMed ID: 9442390
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
Baek SJ; Kim JS; Moore SM; Lee SH; Martinez J; Eling TE
Mol Pharmacol; 2005 Feb; 67(2):356-64. PubMed ID: 15509713
[TBL] [Abstract][Full Text] [Related]
24. Evolutionary conservation of the egr-1 immediate-early gene response in a teleost.
Burmeister SS; Fernald RD
J Comp Neurol; 2005 Jan; 481(2):220-32. PubMed ID: 15562507
[TBL] [Abstract][Full Text] [Related]
25. Zinc finger transcription factor Egr-1 is involved in stimulation of NHE2 gene expression by phorbol 12-myristate 13-acetate.
Malakooti J; Sandoval R; Memark VC; Dudeja PK; Ramaswamy K
Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G653-63. PubMed ID: 15976391
[TBL] [Abstract][Full Text] [Related]
26. EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.
Liu C; Calogero A; Ragona G; Adamson E; Mercola D
Crit Rev Oncog; 1996; 7(1-2):101-25. PubMed ID: 9109500
[TBL] [Abstract][Full Text] [Related]
27. Evidence that activation of the Egr-1 promoter by v-Raf involves serum response elements.
Rim M; Qureshi SA; Gius D; Nho J; Sukhatme VP; Foster DA
Oncogene; 1992 Oct; 7(10):2065-8. PubMed ID: 1408148
[TBL] [Abstract][Full Text] [Related]
28. Sustained induction of egr-1 by v-src correlates with a lack of fos-mediated repression of the egr-1 promoter.
Qureshi SA; Rim MH; Alexandropoulos K; Berg K; Sukhatme VP; Foster DA
Oncogene; 1992 Jan; 7(1):121-5. PubMed ID: 1741159
[TBL] [Abstract][Full Text] [Related]
29. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.
Levin WJ; Press MF; Gaynor RB; Sukhatme VP; Boone TC; Reissmann PT; Figlin RA; Holmes EC; Souza LM; Slamon DJ
Oncogene; 1995 Oct; 11(7):1261-9. PubMed ID: 7478546
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of serum response factor by casein kinase II: evidence against a role in growth factor regulation of fos expression.
Manak JR; Prywes R
Oncogene; 1993 Mar; 8(3):703-11. PubMed ID: 8437853
[TBL] [Abstract][Full Text] [Related]
31. Transactivation of Krox-20 and Krox-24 promoters by the HTLV-1 Tax protein through common regulatory elements.
Alexandre C; Charnay P; Verrier B
Oncogene; 1991 Oct; 6(10):1851-7. PubMed ID: 1833716
[TBL] [Abstract][Full Text] [Related]
32. EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors.
Patwardhan S; Gashler A; Siegel MG; Chang LC; Joseph LJ; Shows TB; Le Beau MM; Sukhatme VP
Oncogene; 1991 Jun; 6(6):917-28. PubMed ID: 1906159
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Egr-1-dependent gene expression by the C-terminal activation domain.
Gosslar U; Schmid RM; Holzmann B
Biochem Biophys Res Commun; 1999 Feb; 255(2):208-15. PubMed ID: 10049687
[TBL] [Abstract][Full Text] [Related]
34. Ternary complex factors Elk-1 and Sap-1a mediate growth hormone-induced transcription of egr-1 (early growth response factor-1) in 3T3-F442A preadipocytes.
Clarkson RW; Shang CA; Levitt LK; Howard T; Waters MJ
Mol Endocrinol; 1999 Apr; 13(4):619-31. PubMed ID: 10194767
[TBL] [Abstract][Full Text] [Related]
35. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.
Huang RP; Liu C; Fan Y; Mercola D; Adamson ED
Cancer Res; 1995 Nov; 55(21):5054-62. PubMed ID: 7585551
[TBL] [Abstract][Full Text] [Related]
36. Expression of early growth response genes in human prostate cancer.
Eid MA; Kumar MV; Iczkowski KA; Bostwick DG; Tindall DJ
Cancer Res; 1998 Jun; 58(11):2461-8. PubMed ID: 9622090
[TBL] [Abstract][Full Text] [Related]
37. The SRE: a growth factor responsive transcriptional regulator.
Treisman R
Semin Cancer Biol; 1990 Feb; 1(1):47-58. PubMed ID: 2133110
[TBL] [Abstract][Full Text] [Related]
38. Alterations in the molecular response to DNA damage during cellular aging of cultured fibroblasts: reduced AP-1 activation and collagenase gene expression.
Choi AM; Pignolo RJ; apRhys CM; Cristofalo VJ; Holbrook NJ
J Cell Physiol; 1995 Jul; 164(1):65-73. PubMed ID: 7790398
[TBL] [Abstract][Full Text] [Related]
39. Activation of the early growth response 1 gene and nuclear pp90rsk in human myeloid leukemia cells by 1-(beta-D-arabinofuranosyl)cytosine.
Kharbanda S; Saleem A; Rubin E; Sukhatme V; Blenis J; Kufe D
Biochemistry; 1993 Sep; 32(35):9137-42. PubMed ID: 7690249
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Egr-1, SRF, and Sp1 mRNA expression in contracting skeletal muscle cells.
Irrcher I; Hood DA
J Appl Physiol (1985); 2004 Dec; 97(6):2207-13. PubMed ID: 15310743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
